Concussion R&D, in general, is a black hole. Astrocyte used 2024 to refine its clinical strategy for its novel drug AST-004 adjusting the trial design to study a more enriched and homogenous concussion population
Tumor necrosis factor -converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells
TB-500 demonstrated the strongest biomechanical improvements with 41 percent greater force to failure
Step 02 Formulation & Purification Every compound has its own proprietary blending process that gently creates a homogeneous solution
Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia
Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cant C